Last viewed:
ISEE
Prices are updated after-hours
ISEE
|
$39.95
0.38%
0.38%
0
|
Health Technology
(0.0% 1d)
(0.2% 1m)
(28.7% 1y)
(0.2% 2d)
(0.6% 3d)
(0.0% 7d)
(-41.69%
volume)
Earnings Calendar: 2023-08-01
Market Cap: $ 5,504,420,783
http://www.ivericbio.com
Sec
Filling
|
Patents
| 38 employees
IVERIC bio, Inc. is a biopharmaceutical company which engages in discovering, developing, and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in New York, NY.
gene therapies
add to watch list
Paper trade
email alert is off
Press-releases
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors
Published: 2024-04-16
(Crawled : 11:00)
- globenewswire.com
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
| 0.21%
| O: -3.69%
H: 5.08%
C: 5.08%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
| 2.36%
| O: -1.31%
H: 2.95%
C: 2.08%
IFRX
|
$1.355
-0.37%
-0.37%
71K
|
Health Technology
| -5.56%
| O: -4.17%
H: 2.17%
C: -5.07%
CLSD
|
News
P
|
$1.33
-2.92%
-3.01%
200K
|
Health Technology
| 10.48%
| O: 1.61%
H: 0.79%
C: -8.73%
Ocular Therapeutix™ Executive Chairman Pravin U. Dugel, MD Becomes President and CEO Antony Mattessich is Stepping Down as President and CEO
Published: 2024-04-15
(Crawled : 11:00)
- globenewswire.com
OCUL
|
News
|
$4.645
-7.1%
-7.64%
3.9M
|
Health Technology
| -39.14%
| O: -5.78%
H: 0.0%
C: 0.0%
ceo
ocular
Astellas Receives Permanent J-code for IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy
Published: 2024-03-26
(Crawled : 13:00)
- ivericbio.com
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
| -12.94%
| O: -1.65%
H: 3.36%
C: 3.17%
Ocular Therapeutix™ Announces Board of Directors and Leadership Updates
Published: 2024-02-22
(Crawled : 12:30)
- globenewswire.com
OCUL
|
News
|
$4.645
-7.1%
-7.64%
3.9M
|
Health Technology
| -33.51%
| O: 20.74%
H: 9.14%
C: 6.83%
ocular
Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor
Published: 2024-02-19
(Crawled : 00:00)
- globenewswire.com
OPT
|
News
|
$3.46
2.98%
2.89%
8.2K
|
Health Technology
| 13.51%
| O: 5.74%
H: 0.32%
C: -3.19%
medical
Opthea Strengthens Team with Key Clinical and Regulatory Hires
Published: 2024-02-01
(Crawled : 11:00)
- globenewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
| -4.46%
| O: 1.55%
H: 0.79%
C: 0.25%
ALC
|
$79.57
-1.47%
0.0%
850K
|
Health Technology
| 7.52%
| O: 0.24%
H: 1.54%
C: 1.46%
OPT
|
News
|
$3.46
2.98%
2.89%
8.2K
|
Health Technology
| 23.99%
| O: -0.74%
H: 6.84%
C: 2.6%
key
Nanoscope Therapeutics Continues Leadership Growth; Welcomes Accomplished Finance and Biotech Leader Glenn Sblendorio as Chairman of the Board
Published: 2023-12-04
(Crawled : 12:00)
- prnewswire.com
ISEE
|
$39.95
0.38%
0.38%
0
|
Health Technology
| Email alert
Add to watchlist
biotech
therapeutics
IZERVAY™ (avacincaptad pegol intravitreal solution) Monthly or Every Other Month Reduced Geographic Atrophy Lesion Growth Through 2 Years
Published: 2023-11-04
(Crawled : 20:20)
- ivericbio.com
ISEE
|
$39.95
0.38%
0.38%
0
|
Health Technology
| Email alert
Add to watchlist
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
| Email alert
Add to watchlist
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
| Email alert
Add to watchlist
growth
Two-time Emmy® Award-Winning Actor, Eric Stonestreet, Partners with Iveric Bio to Raise Awareness of Geographic Atrophy (GA)
Published: 2023-09-20
(Crawled : 14:00)
- ivericbio.com
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
| -36.14%
| O: -0.27%
H: 0.0%
C: -1.21%
emmy
Mineralys Therapeutics Expands its Board of Directors with Appointments of Glenn Sblendorio and Daphne Karydas
Published: 2023-09-14
(Crawled : 20:00)
- globenewswire.com
MLYS
4
|
$11.3
-1.14%
-1.15%
54K
|
| -4.35%
| O: 0.25%
H: 1.34%
C: -3.92%
ICPT
|
$19.0
-0.05%
4M
|
Health Technology
| 64.09%
| O: 0.09%
H: 0.95%
C: -1.12%
FOLD
4
|
$10.52
-1.77%
-1.81%
1.6M
|
Health Technology
| -18.31%
| O: 0.0%
H: 0.95%
C: -0.15%
therapeutics
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001104659-23-080692
4
2023-07-13
2023-07-11
Sell
D
31000
0
0001104659-23-080692
4
2023-07-13
2023-07-11
Sell
D
5000
0
0001104659-23-080692
4
2023-07-13
2023-07-11
Sell
D
32088
0
0001104659-23-080691
4
2023-07-13
2023-07-11
Sell
D
55000
0
0001104659-23-080691
4
2023-07-13
2023-07-11
Sell
D
10000
0
0001104659-23-080691
4
2023-07-13
2023-07-11
Sell
D
44152
0
0001104659-23-080690
4
2023-07-13
2023-07-11
Sell
D
31000
0
0001104659-23-080690
4
2023-07-13
2023-07-11
Sell
D
10000
0
0001104659-23-080690
4
2023-07-13
2023-07-11
Sell
D
13075
0